Search

Author/Creator Soeda, Tetsuhiro

1. Anti‐idiotype monoclonal antibodies against emicizumab enable accurate procoagulant and anticoagulant assays, irrespective of the test base, in the presence of emicizumab. Issue 1 (22nd September 2022)

Authors:
Ogiwara, Kenichi; Furukawa, Shoko; Shinohara, Sho; Tabuchi, Yuka; Arai, Nobuo; Noguchi‐Sasaki, Mariko; Soeda, Tetsuhiro; Shima, Midori; Nogami, Keiji
Journal:
Haemophilia
Issue:
Volume 29:Issue 1(2023)
Page Start:
329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Detailed analysis of anti‐emicizumab antibody decreasing drug efficacy, using plasma samples from a patient with hemophilia A. (28th September 2021)

Authors:
Kaneda, Makoto; Kawasaki, Ryohei; Matsumoto, Naoki; Abe, Hiroto; Tashiro, Yoshihito; Inokuchi, Yuta; Yasuno, Hideyuki; Sasaki‐Noguchi, Mariko; Soeda, Tetsuhiro; Yoshimura, Yasushi; Oka, Toshiaki
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 19:Number 12(2021)
Page Start:
2938
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Emicizumab improves the stability and structure of fibrin clot derived from factor VIII‐deficient plasma, similar to the addition of factor VIII. Issue 3 (11th March 2020)

Authors:
Shimonishi, Naruto; Nogami, Keiji; Ogiwara, Kenichi; Matsumoto, Tomoko; Nakazawa, Fumie; Soeda, Tetsuhiro; Hirata, Michinori; Arai, Nobuo; Shima, Midori
Journal:
Haemophilia
Issue:
Volume 26:Issue 3(2020)
Page Start:
e97
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗